Form 4: Rocket Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

John Militello, Vice President of Finance, Treasurer, and Principal Accounting Officer of Rocket Pharmaceuticals, sold 655 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On May 16, 2025, John Militello, Vice President of Finance, Treasurer, and Principal Accounting Officer of Rocket Pharmaceuticals, sold 655 shares of common stock.
• The sale price was $6.528 per share.
• The transaction was to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Militello directly owns 64,384 shares of Rocket Pharmaceuticals common stock.

Sentiment

Score: 6

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. The sale of shares to cover tax obligations is a neutral event and doesn't necessarily reflect a positive or negative sentiment towards the company's prospects.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The sale of a small number of shares by an executive is unlikely to have a significant impact on shareholders.

Key Dates

Keywords

Rocket Pharmaceuticals, John Militello, stock sale, Form 4, RSUs, tax obligations, beneficial ownership